Healthcare
Novo Nordisk Raises Full-Year Outlook: How the Wegovy Pill Is Driving the Recovery
After earlier challenges, Novo Nordisk delivered strong third-quarter 2026 results. The successful launch of the oral Wegovy version prompted management to raise guidance again.